|
DLPA
How You May Benefit:
-
Elevate mood and well-being
Fight depression by increasing positive attitudes and emotional enthusiasm
-
Control pain
Increase and prolong the body's ability to naturally kill pain by activating endorphins
-
Regulate blood sugar
Reduce alcohol withdrawal by alleviating cravings
-
Suppress appetite
Support fat loss by helping curb sugar and carbohydrate cravings
Overview
DLPA appears to help increase and prolong the body's ability to naturally kill pain because it produces and activates hormones called endorphins, which have an almost "morphine-like" effect.
|
|
Amount: A total of 6 tablets or 2,250 mg per day is reportedly sufficient when starting to supplement with DLPA. Pain relief is usually reported after one week of use.
Timing: Two tablets taken 15 minutes before meals 3 times daily is typically recommended.
Tip: If no substantial pain relief is noticed after three weeks, double the initial amount for two to three more weeks. If it is still not effective, discontinue use. You are most likely one of the few non-responders to this supplement.
|
|
As a potentially powerful pain reliever, DLPA is used by a variety of people—both active and sedentary. It may help relieve pain from whiplash, rheumatoid arthritis, lower back pain, migraines, muscle cramps and soreness, as well as postoperative pain. What's more, it's been shown to be effective for boosting emotional enthusiasm for life and fighting depression.
|
Safety Information
Safety:
DLPA rarely leads to occasional headaches or jitteriness.
Do not use if you have phenylketonuria.
It is not recommended during pregnancy.
Because it may elevate blood pressure, please discuss any DLPA use with your personal health-care practitioner if you have heart disease or high blood pressure.
Toxicity:
None known.
Bans and Restrictions:
None reported.
|
References
Beckmann, H., et al., "DL-Phenylalanine in Depressed Patients: An Open Study," J Neural Transm 41.2-3 (1977) : 123-34.
Beckmann, H., et al., "DL-Phenylalanine Versus Imipramine: A Double-Blind Controlled Study," Archiv Psychiatr Nervekr 227.1 (1979) : 49-58.
Wood, D.R., et al., "Treatment of Attention Deficit Disorder with DL-Phenylalanine," Psychiatry Res. 16.1 (1985) : 21-26.
|
Find the answers fast!
...with the world's most comprehensive online
Supplement Review, with complete in-depth profiles on over 120 supplements
at your fingertips!
View All Supplements
|